Monitoring glutamate levels in the posterior cingulate cortex of thyroid dysfunction patients with TE-averaged PRESS at 3T

Magnetic Resonance Imaging

Volumn 33, Issue 6, 2015, Pages 774-778

  Zhang, Qiujuan ^a   Bai, Zhilan ^a   Gong, Yan ^a   Liu, Xinxin ^a   Dai, Xiaoqing ^a   Wang, Shejiao ^a   Liu, Feng ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Glutamate; Hyperthyroidism; Hypothyroidism; Magnetic resonance spectroscopy; TE averaged PRESS; Thyroid dysfunction

Indexed keywords

CHOLINE; CREATINE; GLUTAMIC ACID; N ACETYLASPARTIC ACID; THYROID HORMONE; ASPARTIC ACID; N-ACETYLASPARTATE;

ADULT; ARTICLE; BRAIN DYSFUNCTION; BRAIN LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; NEUROIMAGING; POSTERIOR CINGULATE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTON NUCLEAR MAGNETIC RESONANCE; THYROID HORMONE BLOOD LEVEL; ANALOGS AND DERIVATIVES; CINGULATE GYRUS; METABOLISM; THYROID DISEASE; THYROID GLAND;

ADULT; ASPARTIC ACID; CHOLINE; CREATINE; FEMALE; GLUTAMIC ACID; GYRUS CINGULI; HUMANS; MALE; PROTON MAGNETIC RESONANCE SPECTROSCOPY; THYROID DISEASES; THYROID GLAND;

EID: 84930924066     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2015.03.004     Document Type: Article

References (25)

1. Bauer M., Silverman D.H., Schlagenhauf F., London E.D., Geist C.L., van Herle K., et al. Brain glucose metabolism in hypothyroidism: a positron emission tomography study before and after thyroid hormone replacement therapy. J Clin Endocrinol Metab 2009, 94(8):2922-2929.
2. Oppenheimer J.H. Evolving concepts of thyroid hormone action. Biochimie 1999, 81(5):539-543.
3. Sanacora G., Zarate C.A., Krystal J.H., Manji H.K. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov 2008, 7(5):426-437.
4. Kandel E.R., Schwartz J.H., Jessell T.M. Neurotransmitters. Principles of neural science 2000, 280-298. McGraw-Hill, New York. M. Hill (Ed.).
5. Salvadore G., Zarate C.A.J. Magnetic resonance spectroscopy studies of the glutamatergic system in mood disorders: a pathway to diagnosis, novel therapeutics, and personalized medicine?. Biol Psychiatry 2010, 68(9):780-782.
6. Krausz Y., Freedman N., Lester H., Barkai G., Levin T., Bocher M., et al. Brain SPECT study of common ground between hypothyroidism and depression. Int J Neuropsychopharmacol 2007, 10(1):99-106.
7. Schreckenberger M.F., Egle U.T., Drecker S., Buchholz H.G., Weber M.M., Bartenstein P., et al. Positron emission tomography reveals correlations between brain metabolism and mood changes in hyperthyroidism. J Clin Endocrinol Metab 2006, 91(12):4786-4791.
8. Mlynárik V., Gruber S., Moser E. Proton T1 and T2 relaxation times of human brain metabolites at 3 Tesla. NMR Biomed 2001, 14(15):325-331.
9. Sailasuta N., Shriner K., Ross B. Evidence of reduced glutamate in the frontal lobe of HIV-seropositive patients. NMR Biomed 2009, 22(3):326-331.
10. Pittenger C., Bloch M.H., Williams K. Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment. Pharmacol Ther 2011, 132(3):314-332.
11. Mendes-de-Aguiar C.B.N., Alchini R., Decker H., Alvarez-Silva M., Tasca C.I., Trentin A.G. Thyroid hormone increases astrocytic glutamate uptake and protects astrocytes and neurons against glutamate toxicity. J Neurosci Res 2008, 86(14):3117-3125.
12. Hallengren B., Falorni A., Landin-Olsson M., Lernmark A., Papadopoulos K.I., Sundkvist G. IsIet ceII and gIutamic acid decarboxyIase antibodies in hyperthyroid patients: at diagnosis and following treatment. J Intern Med 1996, 239(1):63-68.
13. Dagdelen S., Hascelik G., Bayraktar M. Simultaneous triple organ specific autoantibody profiling in adult patients with type 1 diabetes mellitus and their first-degree relatives. Int J Clin Pract 2009, 63(3):449-456.
14. Ghawil M., Tonutti E., Abusrewil S., Visentini D., Hadeed I., Miotti V., et al. Autoimmune thyroid disease in Libyan children and young adults with type 1 diabetes mellitus. Eur J Pediatr 2011, 170(8):983-987.
15. Maddock R.J., Casazza G.A., Buonocore M.H., Tanase C. Vigorous exercise increases brain lactate and Glx (glutamate plus glutamine): a dynamic 1H-MRS study. Neuroimage 2011, 57(4):1324-1330.
16. Bernal J. Action of thyroid hormone in brain. J Endocrinol Invest 2002, 25(3):268-288.
17. Cooper-Kazaz R., Apter J.T., Cohen R., Karagichev L., Muhammed-Moussa S., Grupper D., et al. Combined treatment with sertraline and liothyronine in major depression - a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 2007, 64(6):679-688.
18. Yen P.M. Physiological and molecular basis of thyroid hormone action. Physiol Rev 2001, 81(3):1097-1142.
19. Liu X., Bai Z., Liu F., Li M., Zhang Q., Song G., et al. Reduced posterior cingulate glutamate measured by magnetic resonance spectroscopy in hyperthyroidism. Neuro Endocrinol Lett 2012, 33(6):626-630.
20. Whybrow P.C., Prange A.J. A hypothesis of thyroid-catecholamine- receptor interaction - its relevance to affective-illness. Arch Gen Psychiatry 1981, 38(1):106-113.
21. Sailasuta N., Ernst T., Chang L. Regional variations and the effects of age and gender on glutamate concentrations in the human brain. Magn Reson Imaging 2008, 26(5):667-675.
22. Bondy G.P. Pathology 425 cerebrospinal fluid (CSF) at the Department of Pathology and Laboratory Medicine at the University of British Columbia 2011.
23. Due C.O., Weber O.M., Trabesinger A.H., Meier D., Boesiger P. Magn Reson Med 1998, 39(3):491-496. [Wiley Subscription Services Inc., A Wiley Company]. 10.1002/mrm.1910390320.
24. Zhang H., Zhai S.D., Li Y.M., Chen L.R. J Chromatogr B Analyt Technol Biomed Life Sci 2003, 784(1):131-135.
25. Schubert F., Gallinat J., Seifert F., Rinneberg H. Neuroimage 2004, 21(4):1762-1771. 10.1016/j.neuroimage.2003.11.014.